KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Notes Payables (2016 - 2026)

Johnson & Johnson's Notes Payables history spans 18 years, with the latest figure at $17.5 billion for Q1 2026.

  • On a quarterly basis, Notes Payables rose 25.64% to $17.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $17.5 billion, a 25.64% increase, with the full-year FY2025 number at $8.5 billion, up 41.99% from a year prior.
  • Notes Payables hit $17.5 billion in Q1 2026 for Johnson & Johnson, up from $8.5 billion in the prior quarter.
  • Over the last five years, Notes Payables for JNJ hit a ceiling of $18.0 billion in Q2 2023 and a floor of $3.5 billion in Q4 2023.
  • Historically, Notes Payables has averaged $8.5 billion across 5 years, with a median of $7.4 billion in 2025.
  • The widest YoY moves for Notes Payables: up 318.41% in 2023, down 72.95% in 2023.
  • Tracing JNJ's Notes Payables over 5 years: stood at $4.4 billion in 2022, then decreased by 21.99% to $3.5 billion in 2023, then soared by 73.37% to $6.0 billion in 2024, then surged by 41.99% to $8.5 billion in 2025, then surged by 105.53% to $17.5 billion in 2026.
  • Business Quant data shows Notes Payables for JNJ at $17.5 billion in Q1 2026, $8.5 billion in Q4 2025, and $6.4 billion in Q3 2025.